skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Antibody evolution immunogens

Patent ·
OSTI ID:1771680

The present invention relates, in general, to HIV-1 and, in particular, to broadly neutralizing HIV-1 antibodies, and to HIV-1 immunogens and to methods of using such immunogens to induce the production of broadly neutralizing HIV-1 antibodies in a subject (e.g., a human).

Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC52-06NA25396
Assignee:
Duke University (Durham, NC); Triad National Security, LLC (Los Alamos, NM); The Trustees of the University of Pennsylvania (Philadelphia, PA); TRUSTEES OF BOSTON UNIVERSITY (Boston, MA); The United States of America, as represented by the Secretary, Department of Health and Human Services (Rockville, MD); The Board of Trustees of the Leland Stanford Junior University (Palo Alto, CA)
Patent Number(s):
10,849,970
Application Number:
15/864,822
OSTI ID:
1771680
Resource Relation:
Patent File Date: 01/08/2018
Country of Publication:
United States
Language:
English

References (81)

Predominant Autoantibody Production by Early Human B Cell Precursors journal September 2003
Influenza Virus H5 DNA Vaccination Is Immunogenic by Intramuscular and Intradermal Routes in Humans journal September 2012
Polyclonal B Cell Responses to Conserved Neutralization Epitopes in a Subset of HIV-1-Infected Individuals journal August 2011
Differential Reactivity of Germ Line Allelic Variants of a Broadly Neutralizing HIV-1 Antibody to a gp41 Fusion Intermediate Conformation journal September 2011
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5 journal November 1996
Vaccine patent-application November 2014
Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens journal December 2009
Nonviral delivery of self-amplifying RNA vaccines journal August 2012
Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein journal July 2012
Antibody polyspecificity and neutralization of HIV-1: A hypothesis journal May 2006
Therapeutic antibodies, vaccines and antibodyomes journal May 2010
Phaser crystallographic software journal July 2007
Effects of inefficient cleavage of the signal sequence of HIV-1 gp 120 on its association with calnexin, folding, and intracellular transport. journal September 1996
[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation journal September 2010
Inference of Macromolecular Assemblies from Crystalline State journal September 2007
The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection journal June 2009
A Simple, Fast, and Accurate Algorithm to Estimate Large Phylogenies by Maximum Likelihood journal October 2003
PHENIX : building new software for automated crystallographic structure determination journal October 2002
Two Distinct Broadly Neutralizing Antibody Specificities of Different Clonal Lineages in a Single HIV-1-Infected Donor: Implications for Vaccine Design journal February 2012
DNA/NYVAC Vaccine Regimen Induces HIV-Specific CD4 and CD8 T-Cell Responses in Intestinal Mucosa journal October 2011
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals journal March 2009
Antibody neutralization and escape by HIV-1 journal March 2003
Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies journal June 2005
Measurement and Clinical Monitoring of Human Lymphocyte Clonality by Massively Parallel V-D-J Pyrosequencing journal December 2009
HIV-1 Antibodies patent-application October 2012
The Newick utilities: high-throughput phylogenetic tree processing in the UNIX shell journal May 2010
Reconstructing a B-cell clonal lineage. I. Statistical inference of unobserved ancestors journal January 2013
B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study journal May 2012
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding journal July 2011
Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors journal July 2011
A method for identification of HIV gp140 binding memory B cells in human blood journal April 2009
Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Elicits Human Immunodeficiency Virus Type 1 Envelope-Specific T Lymphocytes at Mucosal Sites journal July 2007
The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection journal March 2011
Broad neutralization coverage of HIV by multiple highly potent antibodies journal September 2011
Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia journal October 2008
The Role of Antibody Polyspecificity and Lipid Reactivity in Binding of Broadly Neutralizing Anti-HIV-1 Envelope Human Monoclonal Antibodies 2F5 and 4E10 to Glycoprotein 41 Membrane Proximal Envelope Epitopes journal March 2007
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand journal December 2009
A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses journal September 2006
HIV vaccine design: the neutralizing antibody conundrum journal June 2012
Rapid evolution of the neutralizing antibody response to HIV type 1 infection journal March 2003
Polyreactive antibodies in adaptive immune responses to viruses journal November 2011
Most rhesus macaques infected with the CCR5-tropic SHIVAD8 generate cross-reactive antibodies that neutralize multiple HIV-1 strains journal November 2012
Increased Immune Response Elicited by DNA Vaccination with a Synthetic gp120 Sequence with Optimized Codon Usage journal February 1998
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 journal July 2010
Motif-optimized subtype A HIV envelope-based DNA vaccines rapidly elicit neutralizing antibodies when delivered sequentially journal August 2012
The rapid generation of mutation data matrices from protein sequences journal January 1992
High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies journal June 2009
Isolation of a Human Anti-HIV gp41 Membrane Proximal Region Neutralizing Antibody by Antigen-Specific Single B Cell Sorting journal September 2011
Specificity of the autologous neutralizing antibody response journal January 2009
Improved NYVAC-Based Vaccine Vectors journal November 2011
Induction of Immunity to Human Immunodeficiency Virus Type-1 by Vaccination journal October 2010
PGV04, an HIV-1 gp120 CD4 Binding Site Antibody, Is Broad and Potent in Neutralization but Does Not Induce Conformational Changes Characteristic of CD4 journal February 2012
New templates for HIV-1 antibody-based vaccine design journal August 2010
Envelope Deglycosylation Enhances Antigenicity of HIV-1 gp41 Epitopes for Both Broad Neutralizing Antibodies and Their Unmutated Ancestor Antibodies journal September 2011
Normalization of B Cell Counts and Subpopulations after Antiretroviral Therapy in Chronic HIV Disease journal February 2008
Deletion of the Beta 20-21 Loop in HIV GP120 Exposes the CD4 Binding Site for Improved Antibody Binding and Antibody Induction patent-application August 2010
Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2 journal January 2013
Antibody evolution immunogens patent June 2018
Algorithm-driven Artifacts in median polish summarization of Microarray data journal November 2010
Generation of Mucosal Anti-Human Immunodeficiency Virus Type 1 T-Cell Responses by Recombinant Mycobacterium smegmatis journal November 2006
Modified HIV-1 Envelope Proteins patent-application September 2009
Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies journal September 2012
APE: Analyses of Phylogenetics and Evolution in R language journal January 2004
Control of Expression, Glycosylation, and Secretion of HIV-1 gp120 by Homologous and Heterologous Signal Sequences journal October 1994
The Development of CD4 Binding Site Antibodies during HIV-1 Infection journal May 2012
Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. journal January 1994
The immune response during acute HIV-1 infection: clues for vaccine development journal December 2009
Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals journal January 2010
Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses journal July 2012
The CCP4 suite programs for protein crystallography journal September 1994
Coot model-building tools for molecular graphics journal November 2004
Potent and Broad Neutralization of HIV-1 Subtype C by Plasma Antibodies Targeting a Quaternary Epitope Including Residues in the V2 Loop journal January 2011
Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1 journal June 2010
Antibody Evolution Immunogens patent-application December 2015
Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials journal May 2012
Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies journal November 2009
Modified HIV-1 Envelope Proteins patent-application June 2012
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids journal May 2007
Limited Neutralizing Antibody Specificities Drive Neutralization Escape in Early HIV-1 Subtype C Infection journal September 2009
Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs journal January 2013